Schroder Investment Management Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Schroder Investment Management Group’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-77,016	Closed	-$2.56M	–	1413
2020 Q2	$2.56M	Buy	77,016 +20,380	+36%	+$649K	﹤0.01%	785
2020 Q1	$1.59M	Buy	+56,636	New	+$1.58M	﹤0.01%	834
2018 Q4	–	Sell	-47,157	Closed	-$1.24M	–	1327
2018 Q3	$1.24M	Sell	47,157 -24,353	-34%	-$658K	﹤0.01%	886
2018 Q2	$1.42M	Hold	71,510	–	–	﹤0.01%	876
2018 Q1	$1.3M	Hold	71,510	–	–	﹤0.01%	905
2017 Q4	$998K	Hold	71,510	–	–	﹤0.01%	979
2017 Q3	$1.36M	Buy	71,510 +30,043	+72%	+$502K	﹤0.01%	936
2017 Q2	$709K	Hold	41,467	–	–	﹤0.01%	1028
2017 Q1	$547K	Sell	41,467 -42,757	-51%	-$670K	﹤0.01%	1010
2016 Q4	$1.27M	Hold	84,224	–	–	﹤0.01%	877
2016 Q3	$985K	Buy	+84,224	New	+$990K	﹤0.01%	930

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Schroder Investment Management Group's MNTA Position: Q3 2020 in Review

Schroder Investment Management Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 77,016 shares — an estimated $2.56M sold.

Schroder Investment Management Group first reported a position in MNTA in Q3 2016 and held it in 11 quarters. The position peaked at $2.56M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Schroder Investment Management Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Schroder Investment Management Group sold 77,016 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $2.56M.
Schroder Investment Management Group first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2016 and held it in 11 quarters.
Schroder Investment Management Group's Momenta Pharmaceuticals, Inc. position peaked at $2.56M in Q2 2020.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Schroder Investment Management Group's 13F filing for Q3 2020, filed 13 Nov 2020.